Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?

被引:20
作者
Burkhard, FC [1 ]
Schumacher, M [1 ]
Thalmann, GN [1 ]
Studer, UE [1 ]
机构
[1] Univ Bern, Dept Urol, Bern, Switzerland
关键词
D O I
10.1111/j.1464-410X.2005.05280.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:275 / 278
页数:4
相关论文
共 16 条
[1]  
Bader P., 2004, European Urology Supplements, V3, P16, DOI 10.1016/S1569-9056(04)90057-7
[2]   Is a limited lymph node dissection an adequate staging procedure for prostate cancer? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2002, 168 (02) :514-518
[3]  
BADER P, 2004, EUR UROL, V3, pA55
[4]  
Di Blasio CJ, 2003, J UROLOGY, V169, P456
[5]  
DIBLASIO CJ, 2003, J UROLOGY, V169, pA1708
[6]  
Dimarco DS, 2003, J UROLOGY, V169, P295
[7]  
Heidenreich A., 2004, European Urology Supplements, V3, P16, DOI 10.1016/S1569-9056(04)90056-5
[8]   Current status of cytotoxic chemotherapy in hormone refractory prostate cancer [J].
Heidenreich, A ;
von Knobloch, R ;
Hofmann, R .
EUROPEAN UROLOGY, 2001, 39 (02) :121-130
[9]  
HEIDENREICH A, 2001, EUR UROL SUPPL, V39, pA530
[10]  
HEIDENREICH A, 2004, EUR UROL, V3, pA54